Use of ampicillin/sulbactam and sultamicillin in pediatric infections: A re-evaluation

Journal of International Medical Research

Volumn 29, Issue 4, 2001, Pages 257-269

  Dajani, A S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ampicillin; Bacterial infection; Pediatrics; Sulbactam; Sultamicillin

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CHLORAMPHENICOL; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; PRODRUG; SULTAMICILLIN; TOBRAMYCIN;

ABDOMINAL INFECTION; ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BONE INFECTION; BONE TISSUE; CHILD; CLINICAL STUDY; CONTROLLED STUDY; DIARRHEA; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG SURVEILLANCE PROGRAM; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; EVALUATION; FECES; FEMALE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; LIVER FUNCTION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NAUSEA; PROPHYLAXIS; RASH; REVIEW; SIDE EFFECT; SKIN INFECTION; SKIN MANIFESTATION; SOFT TISSUE INFECTION; SURGERY; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING;

EID: 0034816699     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000102900401     Document Type: Review

References (52)

1. Beta-lactam antibiotics: Their role in the management of infections in children
2. Beta-lactamase production and the role of ampicillin/sulbactam
3. Sulbactam/ampicillin in paediatric infections
4. Ampicillin-sulbactam
5. A review of the pharmacokinetic and pharmacodynamic characteristics of beta-lactam/beta-lactamase inhibitor combination antibiotics in premature infants
6. Nosocomial infections in pediatric patients: A European, multicenter prospective study
7. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996
8. Worldwide pediatric experience with low-dose sultamicillin oral suspension
9. Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone
10. Beta-lactamases and beta-lactamase inhibitors
11. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use
12. In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections
13. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria
14. National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40 000 aerobic clinical isolates from 236 medical centers
15. Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria
16. Pharmacokinetics of sulbactam/ampicillin in humans: A review
17. Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis
18. Single-dose pharmacokinetics of intravenous sulbactam in pediatric patients
19. Pharmacokinetics of ampicillin and sulbactam in pediatric patients
20. Pharmacokinetic study of sulbactam and ampicillin administered concomitantly by intraarterial or intravenous infusion in the newborn
21. Pharmacokinetics of ampicillin in acute appendicitis in children
22. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children
23. The pharmacokinetics of sultamicillin
24. Penetration of ampicillin and sulbactam into human costal cartilage
25. Sultamicillin use in otitis media: Penetration of sulbactam, a beta-lactamase inhibitor, and ampicillin into middle-ear fluid
26. Clinical use of sultamicillin (ampicillin/sulbactam) in children
27. A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections
28. Intravenous sulbactam/ampicillin in the treatment of pediatric infections
29. Sulbactam/ampicillin in children with bacterial infections
30. Treatment of bacterial infections in children with sultamicillin
31. Sulbactam/ampicillin vs. ceforoxime: A comparative clinical evaluation in the treatment of serious infections in children
32. Sulbactam/ampicillin in the treatment of pediatric infections
33. Evaluation of the efficacy and safety of parenteral sulbactam-ampicillin followed by oral sultamicillin for paediatric infections
34. An open comparative study of the efficacy and safety of sultamicillin versus cefaclor in the treatment of acute otitis media in children
35. Comparative study of sultamicillin and amoxicillin-clavulanate: Treatment of acute otitis media
36. A double-blinded comparative study of sultamicillin and potassium penicillin V in the treatment of childhood streptococcal pharyngitis
37. Sulbactam/ampicillin in the treatment of acute epiglottitis in children
38. Ceforoxime-axetil versus ampicillin-sulbactam in therapy of community acquired pneumonia: A randomized multicenter study in 149 children
39. Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections
40. Efficacy of low doses of sultamicillin in urinary tract infection in children
41. Guidelines for clinical care: Anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement
42. Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children
43. A randomized comparative study of sulbactam plus ampicillin vs. metronidazole plus cefotaxime in the management of acute appendicitis in children
44. Postoperative infections: Perioperative prophylaxis in neonatal and pediatric urology. Prospective study
45. Sulbactam/ampicillin in the treatment of epidemic meningococcal meningitis in northern Nigeria
46. Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children
47. Comparative therapeutic results of penicillin plus chloramphenicol versus ampicillin plus sulbactam in childhood meningococcemia
48. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children
49. Sultamicillin in the treatment of superficial skin and soft tissue infections in children
50. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children
51. Sulbactam plus ampicillin: Interim review of efficacy and safety for therapeutic and prophylactic use
52. Observations on oral Sultamicillin-Unasyn CP-45899 therapy of neonatal infections